24180Array
(
    [TITRE_TRAVAIL] => Array
        (
            [0] => Antibiotics in periprosthesic joint infection: what do orthopedic surgeons know ?
        )

    [etablissement] => Array
        (
            [0] => ORTHOPEDIE, Hôpital Charles Nicolle
        )

    [nom] => Array
        (
            [0] => ABAYED
        )

    [prenom] => Array
        (
            [0] => Amal
        )

    [email] => Array
        (
            [0] => amal.abayed@gmail.com
        )

    [telephone] => Array
        (
            [0] => 21110987
        )

    [auteurs] => Array
        (
            [0] => 
 
Nom prénom / Name Surname: ABAYED A.
Email: amal.abayed@gmail.com
Hôpital / Hospital: ORTHOPEDIE, Hôpital Charles Nicolle

 
Nom prénom / Name Surname: BEN ABID A.
Email: benabidahmed9689@gmail.com
Hôpital / Hospital: ORTHOPEDIE, Hôpital Charles Nicolle

 
Nom prénom / Name Surname: DHIFALLAH M.A.
Email: mohamedaminedhifallah96@gmail.com
Hôpital / Hospital: ORTHOPEDIE, Hôpital Charles Nicolle

 
Nom prénom / Name Surname: BENAMMOU A.
Email: adnene.benammou@gmail.com
Hôpital / Hospital: ORTHOPEDIE, Hôpital Charles Nicolle

 
Nom prénom / Name Surname: KOUSRI R.
Email: kousririhem@yahoo.com
Hôpital / Hospital: ANESTHESIOLOGY, Hôpital Charles Nicolle

 
Nom prénom / Name Surname: BEN SALAH M.
Email: mbensalah94@yahoo.fr
Hôpital / Hospital: ORTHOPEDIE, Hôpital Charles Nicolle

        )

    [mots_cles] => Array
        (
            [0] => surgeon, knowledge and attitude, antibiotics, periprosthetic joint infection;

        )

    [event-id] => Array
        (
            [0] => 3663
        )

    [statut] => Array
        (
            [0] => 1
        )

    [forme] => Array
        (
            [0] => none
        )

    [user_email] => Array
        (
            [0] => amal.abayed@gmail.com
        )

    [specialite] => Array
        (
            [0] => Chirurgie orthopédique et traumatologique
        )

    [pays] => Array
        (
            [0] => Tunisie
        )

    [texte_abs] => Array
        (
            [0] => Introduction
Antibiotics are a key point in the management of periprosthetic joint infection. Orthopedics surgeons tend to have excessive prescription of antibiotics to ensure a rapid result. 

Methods
We conducted a web-based survey to evaluate the orthopedic surgeons’ knowledge and attitudes regarding the prescription of antibiotics in managing periprosthetic joint infection.. A serie of 26 questions evaluated the academic level, gender, workplace, habits when it comes to periprosthetic joint infection management.

Results
A total of 60 surgeons participated in this survey and were mainly residents (61.7%). Predominant age range was 30-40 years old. Most doctors (90%) work at a teaching hospital. 38.3% prescribe antibiotics to young patients under 65 years old, who underwent hip arthroplasty over 36.7% for knee knee arthroplasty. 45% prescribe antibiotics to old patients over 65 years old who underwent hip arthroplasty over 43.3% for knee arthroplasty. Surgeons working in the private sector stated that they prescribed postoperative antibiotics for hip and knee arthroplasties. Surgeons stated they prescribed as a first line antibiotics the following molecules : amoxicillinclavulanicacid and fluoroquinolone (30%), Vancomycin Piperacillintazobactam (23.4%), amoxicillinclavulanicacid and gentamycin (21.7%), Ofloxacin and rifampicin (10%). All surgeons considered associating two antibiotics in the absence of infection documentation and in health-care associated infections. All surgeons performed bacteriological samples. Only 83.3% adapted the treatment according to the results. 63.3% often asked an expert in infectious diseases. Surgeons stated that the main difficulty facing infections management when it comes to medical treatment was the delay of bacteriological sampling results in 68.3%, lack of national recommendations regarding antibiotics in 63.3%, availability of oral treatment in 55%, antibiotics shortage in hospitals in 51.7%, medications allergies in 28.3% and adaptation to renal function in 25%. Only 36.7% used vancomycin powder mostly in arthroplasty and revision.

Conclusion
Emerging antimicrobial resistance and the lack of new molecules represents a real threat to clinicians added to long intravenous treatment in periprosthetic infection resulting in high cost. Prevention remains the key prior to infection. Optimal management includes a collaboration between an infectologist and surgeon.
        )

    [rank_math_internal_links_processed] => Array
        (
            [0] => 1
        )

    [ple-content_has_sections] => Array
        (
            [0] => 
        )

    [_eael_post_view_count] => Array
        (
            [0] => 21
        )

    [trx_addons_post_views_count] => Array
        (
            [0] => 19
        )

    [ekit_post_views_count] => Array
        (
            [0] => 19
        )

    [trx_addons_post_likes_count] => Array
        (
            [0] => 0
        )

)